Covered recipient · General Payments record
LAUREN RUDELL SHEPARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$207.10
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.10 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $97.09 | 5 |
| ABBVIE INC. | $28.47 | 2 |
| Vanda Pharmaceuticals Inc. | $28.32 | 1 |
| Phathom Pharmaceuticals, Inc. | $19.84 | 1 |
| Sumitomo Pharma America, Inc. | $17.55 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.83 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $207.10 | 11 |
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.55 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108186991 | CMS |
| ABBVIE INC. | $14.92 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108186993 | CMS |
| Novo Nordisk Inc | $16.92 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588515 | CMS |
| Novo Nordisk Inc | $18.73 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588311 | CMS |
| Novo Nordisk Inc | $16.81 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100358250 | CMS |
| Novo Nordisk Inc | $20.58 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100378293 | CMS |
| Novo Nordisk Inc | $24.05 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100555187 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.84 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151204903 | CMS |
| Sumitomo Pharma America, Inc. | $17.55 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148994634 | CMS |
| Vanda Pharmaceuticals Inc. | $28.32 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133969516 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.83 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144632635 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.